Terms: = Prostate cancer AND PTPN13, PTP1E, 5783, ENSG00000163629, PTPLE, PTPL1, PNP1, PTP-BAS, DKFZp686J1497, Q12923, FAP-1, PTP-BL AND Treatment
4 results:
1. Three-month posttreatment prostate-specific antigen level as a biomarker of treatment response in patients with intermediate-risk or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy.
Bryant AK; D'Amico AV; Nguyen PL; Einck JP; Kane CJ; McKay RR; Simpson DR; Mundt AJ; Murphy JD; Rose BS
Cancer; 2018 Jul; 124(14):2939-2947. PubMed ID: 29727915
[TBL] [Abstract] [Full Text] [Related]
2. Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95.
Das A; Durrant D; Mitchell C; Dent P; Batra SK; Kukreja RC
Oncotarget; 2016 Jan; 7(4):4399-413. PubMed ID: 26716643
[TBL] [Abstract] [Full Text] [Related]
3. ptpl1 and PKCδ contribute to proapoptotic signalling in prostate cancer cells.
Castilla C; Chinchón D; Medina R; Torrubia FJ; Japón MA; Sáez C
Cell Death Dis; 2013 Apr; 4(4):e576. PubMed ID: 23559010
[TBL] [Abstract] [Full Text] [Related]
4. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
[TBL] [Abstract] [Full Text] [Related]